NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/04/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1.55 mln
Float2.76 mln
Earnings Date11/13/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
15
/ 100
Significantly lagging
Debt / Equity
0.00
Debt-free
ROE
-54.39
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Bone Biologics Corporation is a US-based medical company founded in 2004 and headquartered in Burlington, Massachusetts, that develops advanced solutions for spinal bone regeneration. Its main product, NELL-1/DBM, uses a lab-engineered protein to promote precise and targeted bone growth, with applications in spinal fusion, trauma cases, and osteoporosis treatment. The company holds a licensing agreement with UCLA to develop and bring these treatments to market, ultimately serving spine surgeons and patients dealing with bone defects or spinal conditions.
